Company Directory > CRO > Aizant Drug Research Solutions Pvt. Ltd.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aizant Drug Research Solutions Pvt. Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Aizant Drug Research Solutions is an integrated pharmaceutical service provider based in Hyderabad, India. The company offers comprehensive end-to-end drug development solutions, including API research and development, formulation development, clinical research (CRO), and contract development and manufacturing (CDMO) services. Established in 2005, Aizant supports global pharmaceutical and biotechnology clients with a focus on regulatory compliance, quality, and innovation. The company operates state-of-the-art facilities and provides services across the drug development lifecycle, from pre-formulation and analytical testing to clinical trials and commercial-scale manufacturing.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:CDMO/CRO
SIZE & FINANCIALS
Employees:501-1000
Revenue:$30M-$40M
Founded:2005
Ownership:private
Status:operating
FUNDING
Stage:Private
Total Raised:$7M
Investors:InvAscent
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Oral solids, Injectables, Topical, Nasal, Ophthalmic
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:Syngene International, Sai Life Sciences, Aragen Life Sciences, Piramal Pharma Solutions
LEADERSHIP
Key Executives:
Varma Rudraraju - CEO
Ramesh Babu M - Vice President – Quality
LINKS
Website:aizant.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aizant Drug Research Solutions Pvt. Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.